ABD Focused PI Modules for MOC

Focused Practice Improvement Modules

The American Board of Dermatology is pleased to offer diplomates
free focused Practice Improvement modules to fulfill MOC requirements.
These modules are designed to be impactful on your practice and easy to complete.

Completing a Focused PI Module requires the following:

Read the activity description to determine if it is a meaningful exercise for your practice.
Read the recommended references, if desired.
Perform the initial Practice Assessment chart review.
If your practice is already in compliance with the goals of the activity, attest to this, and no further review is necessary.
If your practice is not in compliance, make the necessary changes to your practice and then repeat the Practice Assessment chart review in the time frame described.

Completing a Focused PI module fulfills the Practice Improvement requirement and provides 25 Self-Assessment credits. 

The following exercises are currently available on the ABD’s MOC Educational Portal, with more offerings currently under development. 

  • Anal cancer screening in adults with perianal Human Papilloma Virus disease
  • Appropriate prescribing of opioids for post-operative pain
  • Appropriate timing of ophthalmologic screening for retinopathy in long-term hydroxychloroquine users
  • Assessing for arterial disease and implementing compression for patients with venous leg ulcers
  • Blood Thinner Management in Dermatologic Surgery
  • Checking BMI and counseling weight reduction in overweight pediatric psoriasis patients
  • Contraceptive education prior to starting isotretinoin
  • Early assessment and intervention for infantile hemangiomas
  • Identification of body dysmorphic disorder in dermatology patients undergoing cosmetic treatments
  • Importance of completing a delayed patch test reading
  • Improved Melanoma Pathology Reporting
  • Improving Adherence to Mohs Appropriate Use Criteria in Low-Risk Body Sites
  • Improving genital lichen sclerosus detection in adult patients presenting with morphea
  • Improving osteoporosis screening counseling and prevention for dermatology patients on chronic glucocorticoids
  • Improving pneumococcal vaccination counseling in dermatology patients prior to initiating biologic medications
  • Improving the Readability of Patient Information Handouts
  • Improving smoking cessation efforts in patients with cutaneous squamous cell carcinoma
  • Influenza vaccination for patients treated with immunosuppressive medication for skin disease
  • Limiting oral antibiotic use to 3-6 months for treatment of acne
  • Limiting use of topical and oral antibiotics in atopic dermatitis patients
  • Performing a skin biopsy in patients with suspected pyoderma gangrenosum
  • Prescribing gabapentin to prevent postherpetic neuralgia in patients over 50 with painful acute herpes zoster
  • Reducing Potassium Monitoring in Healthy Young Women on Spironolactone
  • Using Chemowraps for Chemoprevention of Nonmelanoma Skin Cancers in Solid Organ Transplant Recipients
  • Using Retinoids for Chemoprevention of Nonmelanoma Skin Cancers in Solid Organ Transplant Recipients
  • Utilization of imaging in melanoma (PQRS #224)
  • Choosing a step in the Skin Biopsy Pathway to Assess in Your Office (select ONE):
    • Reason(s) for obtaining the biopsy as well as risks are discussed with the patient; informed consent is obtained.
    • Biopsy details are determined: type and size of biopsy, number of biopsies to obtain, body site or sites and location within lesion(s), transport media.
    • Surgical space, equipment, supplies and staff are assembled, and transport media/containers and requisition forms are obtained, labeled and completed.
    • Biopsy(s) is/are obtained and placed into correctly labeled specimen container(s).
    • Methods for documenting biopsy location(s) are performed, especially if skin cancer is suspected to prevent wrong-site surgery.
    • A dressing is applied and aftercare is explained to the patient.
    • Details of biopsy performance are documented.
    • Communication/transportation pathway for biopsy specimen(s) and requisition form(s) from surgical space to dermatopathology laboratory is engaged.
    • The pathology report is transmitted to the clinician who performed the biopsy.
    • The pathology report results and proposed course of action/therapy are communicated to the patient and any additional clinicians who will need this information. If skin cancer has been identified and another clinician will be performing the definitive surgery, the methods of biopsy site documentation are transmitted as well.

 

 

Contact Us

American Board of Dermatology
2 Wells Avenue
Newton, Massachusetts 02459
Office Hours: Mon-Fri,
8:00 a.m. - 4:30 p.m. ET
(617) 910-6400 (Phone/Fax)
Communications@ABDerm.org

Our Mission

To serve the public and profession by setting high standards for dermatologists to earn and maintain Board certification.